Four Cases of Facial Discoid Lupus Erythematosus Successfully Treated with Topical Pimecrolimus or Tacrolimus
Annals of Dermatology
;
: 307-311, 2010.
Article
in English
| WPRIM
| ID: wpr-60733
ABSTRACT
Discoid lupus erythematosus (DLE), which is a cutaneous form of lupus erythematosus (LE), is generally refractory to a wide range of topical or systemic therapies. Although the main treatment option for DLE is topical steroids, it is often ineffective or likely to produce long-term side effects. New drugs, including tacrolimus and pimecrolimus, have been developed to overcome the adverse effects of steroids and treat the lesions of DLE for a prolonged period. We herein report 4 cases of facial DLE successfully treated with therapeutic adjuvants, topical tacrolimus or pimecrolimus.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Steroids
/
Lupus Erythematosus, Discoid
/
Tacrolimus
Language:
English
Journal:
Annals of Dermatology
Year:
2010
Type:
Article
Similar
MEDLINE
...
LILACS
LIS